8. Danaher
Washington, D.C.
2018 revenue: $15,573,500,000
Fiscal year ending: Dec. 31, 2018
Last year’s rank: 8
Key Personnel:
Thomas Joyce Jr., president & CEO; Daniel Comas, EVP; Matt McGrew, EVP, CFO; Rainer Blair, EVP; William Daniel II, EVP; Joakim Weidemanis, EVP; Brian Ellis, SVP, GC; William King IV, SVP, strategic development; Angela Lalor, SVP, HR; Robert Lutz, SVP, chief accounting officer; Daniel Raskas, SVP, corporate development
Description:
Danaher (NYSE:DHR) remains on track to turn its dental business into a new publicly-traded company called Envista before the end of the year. The dental business makes dental prosthetics, orthodontic bracket systems and much more. Washington, D.C.-based Danaher is also moving forward with its planned $21 billion acquisition of GE Biopharma. The diagnostics business makes analytical instruments, reagents, consumables, software and services. The life sciences business makes research tools to study genes, proteins, metabolites and cells, as well as filtration, separation and purification technologies used in medical and other sectors. – CN